Large addressable market seeBOOST targets a growing unmet need in AMD and DR visual assistance, with a U.S. market potential of over 2.2 million AMD patients and at least 750,000 DR patients, indicating substantial sales opportunities as the population ages.

Healthcare partnerships Opportunity to engage ophthalmology clinics, retinal specialists, and vision rehabilitation centers as channel partners or pilot sites to drive clinical adoption and referrals for seeBOOST.

Evidence and differentiation Position seeBOOST as a proprietary, cost-effective alternative to existing head or spectacle-mounted devices, emphasizing improved all-day usability to address a key consumer need and outperform current solutions.

Digital footprint Leverage the company’s online presence and tech stack (AWS, Webflow, analytics tools) to run targeted digital outreach, patient education campaigns, and demand generation for ophthalmology stakeholders.

Funding and scale With revenue in the low millions and recent funding, there is an opportunity to present a scalable sales plan to potential investors or grant programs, highlighting market expansion and strategic partnerships as growth engines.